Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2407365
Max Phase: Preclinical
Molecular Formula: C27H35N3O5
Molecular Weight: 481.59
Molecule Type: Small molecule
Associated Items:
ID: ALA2407365
Max Phase: Preclinical
Molecular Formula: C27H35N3O5
Molecular Weight: 481.59
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H]([C@H](O)c1ccccc1)N1CN(C)[C@@H](CC(C)C)C1=O
Standard InChI: InChI=1S/C27H35N3O5/c1-18(2)15-22-26(33)30(17-29(22)3)23(24(31)20-13-9-6-10-14-20)25(32)28-21(27(34)35-4)16-19-11-7-5-8-12-19/h5-14,18,21-24,31H,15-17H2,1-4H3,(H,28,32)/t21-,22-,23-,24+/m0/s1
Standard InChI Key: XVCCUGAXGDZMOX-NEWJYFPISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 481.59 | Molecular Weight (Monoisotopic): 481.2577 | AlogP: 2.14 | #Rotatable Bonds: 10 |
Polar Surface Area: 99.18 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.30 | CX Basic pKa: 3.74 | CX LogP: 3.12 | CX LogD: 3.12 |
Aromatic Rings: 2 | Heavy Atoms: 35 | QED Weighted: 0.50 | Np Likeness Score: 0.67 |
1. Mostardeiro MA, Ilha V, Dahmer J, Caro MS, Dalcol II, da Silva UF, Morel AF.. (2013) Cyclopeptide alkaloids: stereochemistry and synthesis of the precursors of discarines C and D and myrianthine A., 76 (7): [PMID:23819826] [10.1021/np400313w] |
Source(1):